In addition, the CRISPR-Cas9 system has been used to rectify SOD1 mutations in models of ALS, thereby reinstating standard protein functionality and enhancing the survival of motor neurones (Gaj et al., 2017). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.